Transforming health through research

Cancer patient first in Canada to be treated with a rare radioisotope 

A team at London Health Sciences Centre Research Institute (LHSCRI) is the first in Canada to treat a patient with neuroendocrine tumours – a rare form of cancer – using a radioisotope called actinium-225 DOTATATE.

London Health Sciences Centre Research Institute drives forward medical breakthroughs that transform health for children and adults around the world.

As the research institute of London Health Sciences Centre, our teams conduct research where patient care is delivered, working alongside patients, families, health-care providers, and academic partners like Western University.

Dr. Laidley in front of scan images on a computer.

Research Programs

Clinical Trials

Research Programs

Our researchers are leaders in advancing the understanding, diagnosis, treatment and management of multiple diseases and health conditions. Our research aligns directly to care programs and clinical expertise at London Health Sciences Centre (LHSC).

Cancer

Cardiology and Vascular Diseases

Children’s Health

Critical Illness

Imaging

Mental Health

Nephrology

Neurological Disorders

Orthopaedics

Personalized Medicine

Surgery

Transplantation